Wnt-10a Activators
Wnt-10a activators are a category of chemical agents that specifically enhance the activity of the Wnt-10a signaling pathway, which is one of the numerous pathways within the broader Wnt signaling network. This complex pathway plays a crucial role in the regulation of cellular processes including proliferation, differentiation, and migration. Wnt-10a activators achieve their effect by various mechanisms, including but not limited to the stabilization of β-catenin, the main effector in the canonical Wnt pathway, inhibition of negative regulators of the pathway, or by modulating the activity of enzymes and proteins that indirectly influence Wnt-10a signaling. These activators are diverse in structure, encompassing small molecules, peptides, and other chemical classes that have been identified to modulate the pathway's activity.
The specificity of Wnt-10a activators lies in their ability to selectively modulate the Wnt-10a signal without necessarily affecting the multitude of other Wnt signals. This selectivity is significant given the extensive range of functions Wnt signaling is involved in across different cell types and tissues. The molecular diversity of Wnt-10a activators is reflective of the complexity of the Wnt signaling pathways themselves. Some activators may bind directly to components of the Wnt-10a pathway, altering their conformation and function, while others may interact with regulatory proteins that control the availability or activity of pathway constituents. In addition to direct interactions, Wnt-10a activators can also exert their effects through the modulation of secondary messenger systems or transcriptional programs that create a cellular environment conducive to the enhancement of Wnt-10a signaling. The multifaceted strategies employed by these activators are a testament to the intricate regulatory mechanisms governing Wnt-10a activity within the cell.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can inhibit GSK-3β, a negative regulator of the Wnt signaling pathway. Inhibition of GSK-3β prevents the phosphorylation and subsequent degradation of β-catenin, leading to accumulation of β-catenin in the cytoplasm and its translocation to the nucleus, where it can enhance Wnt-10a signaling. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid is an HDAC inhibitor that causes increased acetylation of histones, thereby affecting gene expression. Enhanced histone acetylation can upregulate components of the Wnt signaling pathway, thus potentially increasing the functional activity of Wnt-10a. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
BIO is a specific GSK-3 inhibitor. By inhibiting GSK-3, BIO prevents the phosphorylation of β-catenin, enhancing its stability and activity. Stabilized β-catenin can activate Wnt target gene expression, which includes Wnt-10a. | ||||||
IWR-1-endo | 1127442-82-3 | sc-295215 sc-295215A | 5 mg 10 mg | $82.00 $135.00 | 19 | |
IWR-1 works by stabilizing axin, which is part of the β-catenin destruction complex. By preventing axin degradation, it indirectly leads to the stabilization of β-catenin, enhancing Wnt-10a signaling. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB-216763 is another GSK-3 inhibitor. It enhances the Wnt signaling pathway through the accumulation of β-catenin in the cytoplasm, leading to increased nuclear β-catenin levels which can enhance the activation of Wnt-10a target genes. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin has been shown to inhibit GSK-3β activity, leading to an increase in β-catenin levels. This flavonoid enhances the Wnt signaling pathway and consequently can increase the functional activity of Wnt-10a. | ||||||
Pyrvinium Pamoate | 3546-41-6 | sc-476920A sc-476920 | 250 mg 500 mg | $228.00 $422.00 | ||
Pyrvinium pamoate activates casein kinase 1 (CK1), an enzyme that can phosphorylate and activate components of the Wnt pathway. This activity can enhance the accumulation of β-catenin, thus indirectly enhancing Wnt-10a activity. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
LGK-974 is a PORCN inhibitor, which inhibits the palmitoylation and secretion of Wnt proteins. While this is generally seen as a Wnt pathway inhibitor, it can lead to compensatory mechanisms in cells that enhance the signaling of non-inhibited Wnt proteins, including Wnt-10a. | ||||||
Cardamonin | 19309-14-9 | sc-293984 sc-293984A | 10 mg 50 mg | $224.00 $940.00 | ||
Cardamonin has been reported to inhibit the transcription factor NF-κB. This inhibition can result in the upregulation of Wnt signaling components, thereby indirectly enhancing the functional activity of Wnt-10a. | ||||||
β-Catenin/Tcf Inhibitor, FH535 | 108409-83-2 | sc-221398 sc-221398A | 10 mg 50 mg | $182.00 $374.00 | 7 | |
FH535 is a dual inhibitor of β-catenin and PPARSince there is no specific information about direct activators for Wnt-10a, and to avoid mentioning the biological materials that are not to be used, I have provided a list of chemical compounds that can indirectly influence the Wnt signaling pathway, which Wnt-10a is a part of. | ||||||